u.s. fda gives full approval to gilead sciences' antivirul drug remdesivir as covid-19 treatment
Published 4 years ago • 643 plays • Length 0:36Download video MP4
Download video MP3
Similar videos
-
1:20
gilead stock soars on profits from hiv and cancer drugs
-
4:00
gilead ceo daniel o'day on acquisition of cancer drugmaker immunomedics
-
3:29
gilead to buy immunomedics, expanding cancer drug portfolio
-
3:19
episode 1: defining possible
-
3:06
gilead sciences - hot or not
-
2:50
gilead a leader in the hiv medication space: health care researcher
-
5:17
gilead sciences and ejaf announce further five-year radian partnership
-
4:22
closing the hiv diagnosis gap in germany
-
3:33
power within reach | how faith can help fight hiv stigma in the south
-
1:58
cleveland clinic receives $30 million donation from haslams for cardiovascular genetics research
-
1:25
gilead shares sink as the fda rejects the company's arthritis drug
-
8:22
dr. scott gottlieb explains the potential of gilead's coronavirus treatment
-
3:05
gilead compass initiative 5 years, 5 voices: vision community foundation
-
27:02
gilead hepatitis elimination webinar series: harm reduction, pt. 2 – hcsa (singapore)
-
3:36
gilead compass initiative: stigma
-
1:51
u.s. fda gives full approval to gilead sciences' antiviral drug remdesivir as covid-19 treatment
-
1:05
trio win nobel prize for oxygen research
-
4:08
hepatitis c awareness / gilead sciences
-
0:34
gilead hepatitis elimination webinar series: health equity - outro
-
39:43
romas geleziunas (gilead)
-
4:33
gilead's base business for hiv remains strong: biotech analyst
-
3:48
gilead compass initiative: mental health